Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE)
Titel:
Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE)
Auteur:
Saad, Fred Chi, Kim N. Shore, Neal D. Graff, Julie N. Posadas, Edwin M. Lattouf, Jean-Baptiste Espina, Byron M. Zhu, Eugene Yu, Alex Hazra, Anasuya De Meulder, Marc Mamidi, Rao N. V. S. Bradic, Branislav Francis, Peter Hayreh, Vinny Rezazadeh Kalebasty, Arash